EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson’s Disease

Elena V Grigor'eva, Alena E Kopytova, Elena S Yarkova, Sophia V Pavlova iD, Diana A Sorogina, Anastasia A Malakhova iD, Tuyana B Malankhanova iD, Galina V Baydakova, Ekaterina Y Zakharova, Sergey P Medvedev iD, Sofia N Pchelina iD, Suren M Zakian

International Journal of Molecular Sciences · 23.02.2023 · 24 (5) · 4437

DOI: 10.3390/ijms24054437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.02.2023. Verfasst von Elena V Grigor'eva und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia. Hauptthemen laut MEDLINE: Parkinson Disease, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GBA variants increase the risk of Parkinson’s disease (PD) by 10 times. The GBA gene encodes the lysosomal enzyme glucocerebrosidase (GCase). The p.N370S substitution causes a violation of the enzyme conformation, which affects its stability in the cell. We studied the biochemical characteristics of dopaminergic (DA) neurons generated from induced pluripotent stem cells (iPSCs) from a PD patient with the GBA p.N370S mutation (GBA-PD), an asymptomatic GBA p.N370S carrier (GBA-carrier), and two healthy donors (control). Using liquid chromatography with tandem mass spectrometry (LC-MS/MS), we measured the activity of six lysosomal enzymes (GCase, galactocerebrosidase (GALC), alpha-glucosidase (GAA), alpha-galactosidase (GLA), sphingomyelinase (ASM), and alpha-iduronidase (IDUA)) in iPSC-derived DA neurons from the GBA-PD and GBA-carrier. DA neurons from the GBA mutation carrier demonstrated decreased GCase activity compared to the control. The decrease was not associated with any changes in GBA expression levels in DA neurons. GCase activity was more markedly decreased in the DA neurons of GBA-PD patient compared to the GBA-carrier. The amount of GCase protein was decreased only in GBA-PD neurons. Additionally, alterations in the activity of the other lysosomal enzymes (GLA and IDUA) were found in GBA-PD neurons compared to GBA-carrier and control neurons. Further study of the molecular differences between the GBA-PD and the GBA-carrier is essential to investigate whether genetic factors or external conditions are the causes of the penetrance of the p.N370S GBA variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseInduced Pluripotent Stem CellsHumansGlucosylceramidaseDopaminergic NeuronsChromatography, LiquidTandem Mass Spectrometry

Stichwörter der Autor:innen

ambroxolasymptomatic mutation carrierdopaminergic neuronsglucocerebrosidaseinduced pluripotent stem cellsmutation in the GBA geneneural differentiation

Substanzen

Glucosylceramidase

Autor:innen und Institutionen

  • Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia.
  • Petersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Center «Kurchatov Institute», Gatchina 188300, Russia.
  • Department of Molecular Genetic and Nanobiological Technologies, Scientific and Research Centre, Pavlov First Saint-Petersburg State Medical University, Saint-Petersburg 197022, Russia.
  • Research Centre for Medical Genetics, Moscow 115522, Russia.

ORCID-Profile: Sophia V Pavlova, Anastasia A Malakhova, Tuyana B Malankhanova, Sergey P Medvedev, Sofia N Pchelina

Förderung

  • Russian Science Foundation

Zitieren

APA

Grigor'eva, E. V., Kopytova, A. E., Yarkova, E. S., Pavlova, S. V., Sorogina, D. A., Malakhova, A. A., Malankhanova, T. B., Baydakova, G. V., Zakharova, E. Y., Medvedev, S. P., Pchelina, S. N., & Zakian, S. M. (2023). Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson’s Disease. International Journal of Molecular Sciences, 24(5), 4437. https://doi.org/10.3390/ijms24054437

Vancouver

Grigor'eva EV, Kopytova AE, Yarkova ES, Pavlova SV, Sorogina DA, Malakhova AA, et al. Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson’s Disease. International Journal of Molecular Sciences. 2023;24(5):4437. doi:10.3390/ijms24054437

BibTeX
@article{Grigoreva2023,
  author = {Grigor'eva, Elena V and Kopytova, Alena E and Yarkova, Elena S and Pavlova, Sophia V and Sorogina, Diana A and Malakhova, Anastasia A and Malankhanova, Tuyana B and Baydakova, Galina V and Zakharova, Ekaterina Y and Medvedev, Sergey P and Pchelina, Sofia N and Zakian, Suren M},
  title = {Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S GBA Variant Carriers with and without Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {4437},
  doi = {10.3390/ijms24054437}
}
Kostenlos starten →